Genscript Biotech's total assets for Q2 2025 were $5.43B, an increase of 2.96% from the previous quarter. HK:1548 total liabilities were $1.01B for the fiscal quarter, a 6.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.